The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Differences in response to imatinib between gastrointestinal stromal tumors involving the liver and tumors that do not: Experience from Nairobi.
Nicolas Anthony Othieno-Abinya
No relevant relationships to disclose
Malkit Singh Riyat
No relevant relationships to disclose
Raymond Omollo
No relevant relationships to disclose
Gladwell Wantiru Gichuru
No relevant relationships to disclose